Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/23483
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Çelik, Nilüfer | - |
dc.contributor.author | Bilgin, Tevfik | - |
dc.date.accessioned | 2021-12-23T07:53:47Z | - |
dc.date.available | 2021-12-23T07:53:47Z | - |
dc.date.issued | 2009 | - |
dc.identifier.citation | Özuysal, S. vd. (2009). "Expression of cyclooxygenase-2 in ovarian serous carcinoma: Correlation with angiogenesis, nm23 expression and survival". European Journal of Gynaecological Oncology, 30(6), 640-645. | en_US |
dc.identifier.issn | 0392-2936 | - |
dc.identifier.uri | http://hdl.handle.net/11452/23483 | - |
dc.description.abstract | Objective: To evaluate the expression of cyclooxygenase (COX)-2 in ovarian serous carcinomas (OSC) and its correlation with microvessel density (MVD), nm23 expression, clinicopathologic prognostic factors and survival. Methods: Specimens from 44 patients with OSC were evaluated by immunohistochemistry for COX-2 and nm23 expression. Tumor MVD was assessed with CD34 immunostaining. The survival data of the patients were found from data files. Results: 40 specimens (90.1%) showed positive COX-2 staining. Patients with high COX-2-expressed tumors had shorter overall survival, but it was not statistically significant. No correlation was found between COX-2 expression and clinicopathologic variables. There was no significant correlation between COX-2 and nm23 expression or MVD. Conclusions: COX-2 is frequently expressed in OSC. Although we could not confirm the prognostic significance of Cox-2 expression in the present cohort of OSC patients, the p value for overall Survival was just slightly greater than alpha, and this result can be referred as almost significant. We considered that the limited number of cases in Our study might affect the statistical analysis of our results. Further studies involving a larger number of patients are needed to clarify the prognostic significance of COX-2 expression in ovarian carcinomas. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Imr Press | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Angiogenesis | en_US |
dc.subject | CD34 | en_US |
dc.subject | COX-2 | en_US |
dc.subject | Cyclooxygenase-2 | en_US |
dc.subject | Immunohistochemistry | en_US |
dc.subject | nm23 | en_US |
dc.subject | Ovarian serous carcinoma | en_US |
dc.subject | Prognosis | en_US |
dc.subject | Intestinal epithelial-cells | en_US |
dc.subject | Metastasis-related nm23-h1 | en_US |
dc.subject | Colon-cancer cells | en_US |
dc.subject | Prognostic-significance | en_US |
dc.subject | Tumor angiogenesis | en_US |
dc.subject | Breast-carcinoma | en_US |
dc.subject | Molecular markers | en_US |
dc.subject | Gene-expression | en_US |
dc.subject | Growth | en_US |
dc.subject | Adenocarcinomas | en_US |
dc.subject | Oncology | en_US |
dc.subject | Obstetrics & gynecology | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Cyclooxygenase 2 | en_US |
dc.subject.mesh | Cystadenoma, serous | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Kaplan-meiers estimate | en_US |
dc.subject.mesh | Microvessels | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Neovascularization, pathologic | en_US |
dc.subject.mesh | NM23 nucleoside diphosphate kinases | en_US |
dc.subject.mesh | Ovarian neoplasms | en_US |
dc.subject.mesh | Survival analysis | en_US |
dc.title | Expression of cyclooxygenase-2 in ovarian serous carcinoma: Correlation with angiogenesis, nm23 expression and survival | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000271614400008 | tr_TR |
dc.identifier.scopus | 2-s2.0-70949090063 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı. | tr_TR |
dc.relation.bap | T-2006/15 | tr_TR |
dc.contributor.orcid | 0000-0002-9732-5340 | tr_TR |
dc.identifier.startpage | 640 | tr_TR |
dc.identifier.endpage | 645 | tr_TR |
dc.identifier.volume | 30 | tr_TR |
dc.identifier.issue | 6 | tr_TR |
dc.relation.journal | European Journal of Gynaecological Oncology | en_US |
dc.contributor.buuauthor | Özuysal, Sema | - |
dc.contributor.buuauthor | Evrensel, Türkkan | - |
dc.contributor.buuauthor | Özgür, Tümay | - |
dc.contributor.researcherid | AAJ-1027-2021 | tr_TR |
dc.contributor.researcherid | AAA-1530-2020 | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.identifier.pubmed | 20099494 | tr_TR |
dc.subject.wos | Oncology | en_US |
dc.subject.wos | Obstetrics & gynecology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | Pubmed | en_US |
dc.wos.quartile | Q4 | en_US |
dc.contributor.scopusid | 56616314600 | tr_TR |
dc.contributor.scopusid | 54584171000 | tr_TR |
dc.contributor.scopusid | 54584171000 | tr_TR |
dc.subject.scopus | Cyclooxygenase 2; Celecoxib; Prostaglandin Synthase | en_US |
dc.subject.emtree | Cyclooxygenase 2 | en_US |
dc.subject.emtree | Nucleoside diphosphate kinase NM23 | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Aged | en_US |
dc.subject.emtree | Angiogenesis | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Cancer survival | en_US |
dc.subject.emtree | Clinical article | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Human tissue | en_US |
dc.subject.emtree | Ovary carcinoma | en_US |
dc.subject.emtree | Prognosis | en_US |
dc.subject.emtree | Protein expression | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.